444

MIDDLE EAST PHARMACEUTICAL INDUSTRIES CO.

No trades
See on Supercharts

4016 fundamentals

MIDDLE EAST PHARMACEUTICAL INDUSTRIES CO. financial statements, including revenue, expenses, profit, and loss

The total revenue of 4016 for the last quarter is 81.06 M SAR, and it's 19.85% lower compared to the previous quarter. The net income of Q3 24 is 3.87 M SAR.

Q2 '22
Q2 '23
Q1 '24
Q2 '24
Q3 '24
‪0.00‬
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: SAR
Q2 '22
Q2 '23
Q1 '24
Q2 '24
Q3 '24
TTM
Total revenueYoY growth
Gross profitYoY growth
Pretax incomeYoY growth
Net incomeYoY growth
EBITDAYoY growth
EBITYoY growth